OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Bibliometric and visualized analysis of drug resistance in ovarian cancer from 2013 to 2022
Jiahua Liu, Junnan Ma, Jiarong Zhang, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 8
Jiahua Liu, Junnan Ma, Jiarong Zhang, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 8
Showing 8 citing articles:
CRABP2 affects chemotherapy resistance of ovarian cancer by regulating the expression of HIF1α
Xin Fu, Qian Zhang, Zhaosong Wang, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 10
Xin Fu, Qian Zhang, Zhaosong Wang, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 10
TGF β1 promotes the polarization of M2-type macrophages and activates PI3K/mTOR signaling pathway by inhibiting ISG20 to sensitize ovarian cancer to cisplatin
Jianfa Wu, Lingli Jiang, Sihong Wang, et al.
International Immunopharmacology (2024) Vol. 134, pp. 112235-112235
Closed Access | Times Cited: 3
Jianfa Wu, Lingli Jiang, Sihong Wang, et al.
International Immunopharmacology (2024) Vol. 134, pp. 112235-112235
Closed Access | Times Cited: 3
Past and present: a bibliometric study on the treatment of recurrent ovarian cancer
Xiao-yuan Hao, Wen-wei Song, Miaoling Li, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1
Xiao-yuan Hao, Wen-wei Song, Miaoling Li, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1
Revised Cut-Off Value of Human Epididymis Protein 4 Enhances Its Use as an Ovarian Tumor Marker
Hiroki Machida, Takashi Hirakawa, Katsuhiko Tsunekawa, et al.
Gynecologic and Obstetric Investigation (2023) Vol. 88, Iss. 6, pp. 349-358
Closed Access | Times Cited: 3
Hiroki Machida, Takashi Hirakawa, Katsuhiko Tsunekawa, et al.
Gynecologic and Obstetric Investigation (2023) Vol. 88, Iss. 6, pp. 349-358
Closed Access | Times Cited: 3
Dual-Targeted Zeolitic Imidazolate Frameworks Drug Delivery System Reversing Cisplatin Resistance to Treat Resistant Ovarian Cancer
Yan Xing, Rui Jing, Xiaoying Tang, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 6603-6618
Open Access
Yan Xing, Rui Jing, Xiaoying Tang, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 6603-6618
Open Access
Fabrication of co-delivery liposomal formulation incorporating carmustine and cabazitaxel displays improved cytotoxic potential and induced apoptosis in ovarian cancer cells
Jianming Gong, Renqian Feng, Xiaoqing Fu, et al.
Journal of Biomaterials Science Polymer Edition (2024) Vol. 36, Iss. 1, pp. 1-21
Closed Access
Jianming Gong, Renqian Feng, Xiaoqing Fu, et al.
Journal of Biomaterials Science Polymer Edition (2024) Vol. 36, Iss. 1, pp. 1-21
Closed Access
The impact of high-intensity interval training on women’s health: A bibliometric and visualization analysis
Youyou Li, Jingqian Fang
Medicine (2024) Vol. 103, Iss. 39, pp. e39855-e39855
Open Access
Youyou Li, Jingqian Fang
Medicine (2024) Vol. 103, Iss. 39, pp. e39855-e39855
Open Access
Application of medical imaging in ovarian cancer: a bibliometric analysis from 2000 to 2022
Yinping Leng, Shuhao Li, Jianghua Zhu, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 1
Yinping Leng, Shuhao Li, Jianghua Zhu, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 1
